WHO ICTRP trial
Efficacy and cost of Stevia rebaudiana Bertoni extract as adjunctive therapy in…
PACTR201410000894447 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR201410000894447 |
|---|---|
| Public title | Efficacy and cost of Stevia rebaudiana Bertoni extract as adjunctive therapy in Sahrawi patients with Type 2 diabetes |
| Scientific title | Efficacy of Stevia rebaudiana Bertoni extract as adjunctive therapy in Sahraoui patients with Type 2 diabetes. A Randomized, Controlled, Cross-over, Double-Blind Trial |
| Primary sponsor | Angela Pallarés |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Morocco |
| Conditions | Nutritional, Metabolic, Endocrine diabetes in developing countries;Nutritional, Metabolic, Endocrine;diabetes in developing countries |
| Interventions | refined sugar (99% sucrose);stevia rebaudiana as sweetener |
| Registration date | Sep 28, 2014 |
| Target size | 79 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: